Edison Oncology Holding Corp
CIK:
0001753347
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
State of Incorporation
NV
Business Address
3475 EDISON WAY, MENLO PARK, CA, 94025
Mailing Address
3475 EDISON WAY, MENLO PARK, CA, 94025
Phone
(650)690-1927
Fiscal Year End
1231
EIN
831614120
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1/A IPO registration amendment | January 30, 2026 | View on SEC |
| S-1/A IPO registration amendment | January 16, 2026 | View on SEC |
| S-1/A IPO registration amendment | December 31, 2025 | View on SEC |
| S-1/A IPO registration amendment | December 16, 2025 | View on SEC |
| S-1 IPO registration statement | November 28, 2025 | View on SEC |
IPO Filings
S-1
November 28, 2025
- Developing precision oncology drugs using a 'smart bomb' approach to target tumors without harming healthy cells.
- Experienced leadership team led by CEO Dr. Maria Chen, who previously launched a blockbuster breast cancer drug.
Related Companies
Companies in the same industry (SIC: 2836)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
HALOZYME THERAPEUTICS, INC.
HALO
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.